Cargando…
ADAM10 Site-Dependent Biology: Keeping Control of a Pervasive Protease
Enzymes, once considered static molecular machines acting in defined spatial patterns and sites of action, move to different intra- and extracellular locations, changing their function. This topological regulation revealed a close cross-talk between proteases and signaling events involving post-tran...
Autores principales: | Tosetti, Francesca, Alessio, Massimo, Poggi, Alessandro, Zocchi, Maria Raffaella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124674/ https://www.ncbi.nlm.nih.gov/pubmed/34067041 http://dx.doi.org/10.3390/ijms22094969 |
Ejemplares similares
-
ADAM10 new selective inhibitors reduce NKG2D ligand release sensitizing Hodgkin lymphoma cells to NKG2D-mediated killing
por: Zocchi, Maria Raffaella, et al.
Publicado: (2015) -
Specific ADAM10 inhibitors localize in exosome-like vesicles released by Hodgkin lymphoma and stromal cells and prevent sheddase activity carried to bystander cells
por: Tosetti, Francesca, et al.
Publicado: (2018) -
How to exploit stress-related immunity against Hodgkin’s lymphoma: Targeting ERp5 and ADAM sheddases
por: Poggi, Alessandro, et al.
Publicado: (2013) -
Inhibitors of ADAM10 reduce Hodgkin lymphoma cell growth in 3D microenvironments and enhance brentuximab-vedotin effect
por: Pece, Roberta, et al.
Publicado: (2021) -
Cancer Nanomedicine Special Issue Review Anticancer Drug Delivery with Nanoparticles: Extracellular Vesicles or Synthetic Nanobeads as Therapeutic Tools for Conventional Treatment or Immunotherapy
por: Zocchi, Maria Raffaella, et al.
Publicado: (2020)